Ignite Creation Date:
2024-05-06 @ 5:47 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05436639
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-17
First Post:
2022-06-23
Brief Title:
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
Sponsor:
Sparrow Pharmaceuticals
Organization:
Sparrow Pharmaceuticals
Organization Data
Organization:
Sparrow Pharmaceuticals
Class:
INDUSTRY
Study ID:
SPI-62-CL-2002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sparrow Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None